Blockade of oncogenic NOTCH1 with the SERCA inhibitor CAD204520 in T cell acute lymphoblastic leukemia
The identification of SERCA (sarco/endoplasmic reticulum calcium ATPase) as a target for modulating gain-of-function NOTCH1 mutations in Notch-dependent cancers has spurred the development of this compound class for cancer therapeutics. Despite the innate toxicity challenge associated with SERCA inh...
Main Authors: | Marchesini, M, Gherli, A, Montanaro, A, Patrizi, L, Sorrentino, C, Pagliaro, L, Rompietti, C, Kitara, S, Heit, S, Olesen, CE, Møller, JV, Savi, M, Bocchi, L, Vilella, R, Rizzi, F, Baglione, M, Rastelli, G, Loiacono, C, La Starza, R, Mecucci, C, Stegmaier, K, Aversa, F, Stilli, D, Lund Winther, A-M, Sportoletti, P, Bublitz, M, Dalby-Brown, W, Roti, G |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Cell Press
2020
|
Similar Items
-
Blockade of oncogenic notch1 with the new serca inhibitor cad204520 in t-cell acute lymphoblastic leukemia
by: M. Marchesini, et al.
Published: (2020-09-01) -
CAD204520 Targets <i>NOTCH1</i> PEST Domain Mutations in Lymphoproliferative Disorders
by: Luca Pagliaro, et al.
Published: (2024-01-01) -
A thermodynamic model of the cardiac sarcoplasmic/endoplasmic Ca2+ (SERCA) pump
by: K., T, et al.
Published: (2008) -
A Large-Scale High-Throughput Screen for Modulators of SERCA Activity
by: Philip A. Bidwell, et al.
Published: (2022-11-01) -
cADPR stimulates SERCA activity in Xenopus oocytes.
by: Yamasaki-Mann, M, et al.
Published: (2009)